Brief Articles
Copyright ©2009 The WJG Press and Baishideng.
World J Gastroenterol. Jul 28, 2009; 15(28): 3493-3497
Published online Jul 28, 2009. doi: 10.3748/wjg.15.3493
Table 3 COX-2 haplotype distribution and corresponding ORs in patients with oesophageal adenocarcinoma or squamous cell carcinoma carcinoma versus controls
Haplotype COX-2Adenocarcinoma
Squamous cell carcinoma
Controls n = 236 (%)
n= 163 (%)OR (95% CI)n= 59 (%)OR (95% CI)
AG/AG59 (36.2)Reference18 (30.5)Reference94 (39.8)
AG/AC29 (17.8)0.87 (0.50-1.52)12 (20.3)1.18 (0.53-2.64)53 (22.4)
AC/AC5 (3.1)1.33 (0.39-4.55)2 (3.4)1.74 (0.33-9.32)6 (2.5)
GC/AC0 (0)-0 (0)-0 (0)
GG/AC17 (10.4)1.29 (0.63-2.64)4 (6.8)0.99 (0.31-3.24)21 (8.9)
GG/AG40 (24.5)1.14 (0.68-1.91)19 (32.2)1.77 (0.86-3.66)56 (23.7)
GG/GG13 (8.0)3.45 (1.24-9.58)4 (6.8)3.48 (0.89-13.6)6 (2.5)